# Hypoxia-induced metastatic heterogeneity in pancreatic cancer

**Authors:** Pradeep Moon Gunasekaran, Qianqian Wang, Yoke-Chen Chang, Polina Guseva, Rajika Chauhan, Alexander Kley, Gene Lee, Siddharth Ghosh Roy, Yousef Masoudpoor, Arthur Roberts, Kelly Watkins Walton, Lucyann Franciosa, Shafiq Bhat, Emmanuel Zachariah, Kishan Patel, Zhongren Zhou, Wenjin Chen, Julie Zhouli Ni, Sam Guoping Gu, Cristina Montagna, Shin-Heng Chiou

PMC · DOI: 10.21203/rs.3.rs-7394295/v1 · Research Square · 2025-10-01

## TL;DR

This study shows how low oxygen conditions in pancreatic cancer cells lead to metastasis by altering gene activity and increasing genetic instability.

## Contribution

The paper identifies Kdm8 as a key target of hypoxia that drives metastasis through epigenetic and genomic changes.

## Key findings

- Hypoxia suppresses Kdm8, leading to transcriptomic changes and metastasis in pancreatic cancer.
- Loss of Kdm8 causes chromosomal instability and increased Kras copy number.
- Demethylase activity of Kdm8 is critical for controlling metastasis under hypoxia.

## Abstract

In most solid tumors, hypoxia is a critical physical attribute that reprograms malignant cells into a highly metastatic state. Specifically, hypoxia is a well-established inducer of cellular plasticity, which is associated with treatment resistance and metastasis. Furthermore, hypoxia exacerbates chromosomal instability (CIN), a hallmark of cancer that can be initiated by the loss of Trp53 and a key contributor to metastasis. Despite this, the mechanisms by which malignant cells concurrently co-opt these elements of hypoxic adaptation to promote metastasis remains unknown. Here we report that hypoxia promotes metastasis by suppressing the JmjC-containing histone lysine demethylase Kdm8. CRISPR/Cas9-mediated targeting of Kdm8 in a Kras;Trp53-driven mouse model of pancreatic ductal adenocarcinoma robustly rewires the malignant cell transcriptomic programs, leading to a profound loss of the epithelial morphology and widespread metastatic disease. Mechanistically, Kdm8 suppression in normoxia recapitulates major aspects of the global epigenetic changes and the transcriptomic rewiring induced by hypoxia. Moreover, Kdm8 deficiency leads to mitotic defects, increased micronuclei formation, Kras copy number gains, and enhanced CIN. Of note, disruption of Kdm8’s demethylase function phenocopies the effects of Kdm8 loss, whereas expression of hypermorphic Kdm8 variants that are resistant to hypoxic suppression reduces metastasis beyond the levels achieved by the wildtype counterpart. Through the suppression of Kdm8 demethylase activity, hypoxia unleashes a potent metastatic program by simultaneously advancing cellular plasticity and CIN.

## Linked entities

- **Genes:** TP53 (tumor protein p53) [NCBI Gene 7157], KDM8 (lysine demethylase 8) [NCBI Gene 79831], KRAS (KRAS proto-oncogene, GTPase) [NCBI Gene 3845]
- **Diseases:** pancreatic ductal adenocarcinoma (MONDO:0005184)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Kdm8 (lysine (K)-specific demethylase 8) [NCBI Gene 77035] {aka 3110005O21Rik, Jmjd5}, Kras (Kras proto-oncogene, GTPase) [NCBI Gene 16653] {aka K-Ras, K-Ras 2, K-ras, Ki-ras, Kras-2, Kras2}, Trp53 (transformation related protein 53) [NCBI Gene 22059] {aka Tp53, bbl, bfy, bhy, p44, p53}
- **Diseases:** pancreatic ductal adenocarcinoma (MESH:D021441), Hypoxia (MESH:D000860), metastasis (MESH:D009362), pancreatic cancer (MESH:D010190), solid (MESH:D018250), CIN (MESH:D043171), hypoxic (MESH:D002534), cancer (MESH:D009369)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12622147/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12622147/full.md

## References

115 references — full list in the complete paper: https://tomesphere.com/paper/PMC12622147/full.md

---
Source: https://tomesphere.com/paper/PMC12622147